Saag MS - Search Results

1

Saag MS, Dumond JB. Saag MS, et al. AIDS. 2019 Nov 1;33(13):2097-2098. doi: 10.1097/QAD.0000000000002314. AIDS. 2019. PMID: 31577573 No abstract available.

2

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, Anderson R, Clendeninn N; Virqacept Collaborative Study Group. Saag MS, et al. AIDS. 2001 Oct 19;15(15):1971-8. doi: 10.1097/00002030-200110190-00009. AIDS. 2001. PMID: 11600825 Clinical Trial.

3

Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study.

McKinnell JA, Lin HY, Nevin CN, Willig JH, McFarland G, Genz M, Raper JL, DeLaitsch LL, Mrus JM, Klaskala W, Mugavero MJ, Saag MS. McKinnell JA, et al. Among authors: saag ms. AIDS. 2009 Jul 31;23(12):1539-46. doi: 10.1097/QAD.0b013e32832c7b5c. AIDS. 2009. PMID: 19487910

4

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ. Yanik EL, et al. AIDS. 2014 Apr 24;28(7):979-87. doi: 10.1097/QAD.0000000000000167. AIDS. 2014. PMID: 24681415 Free PMC article.

5

Decline in locomotor functions over time in HIV-infected patients.

Dorfman D, Saag MS. Dorfman D, et al. Among authors: saag ms. AIDS. 2014 Jun 19;28(10):1531-2. doi: 10.1097/QAD.0000000000000302. AIDS. 2014. PMID: 24896802 No abstract available.

6

A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.

Thompson M, Saag M, DeJesus E, Gathe J, Lalezari J, Landay AL, Cade J, Enejosa J, Lefebvre E, Feinberg J. Thompson M, et al. AIDS. 2016 Mar 27;30(6):869-78. doi: 10.1097/QAD.0000000000000988. AIDS. 2016. PMID: 26636929 Free PMC article. Clinical Trial.

7

Trends in antiretroviral therapy prescription, durability and modification: new drugs, more changes, but less failure.

Eaton EF, Tamhane A, Davy-Mendez T, Mathews WC, Moore RD, Saag MS, Mugavero MJ. Eaton EF, et al. Among authors: saag ms. AIDS. 2018 Jan 28;32(3):347-355. doi: 10.1097/QAD.0000000000001708. AIDS. 2018. PMID: 29194118 Free PMC article.

8

Special section: COVID-19 among people living with HIV.

Saag M. Saag M. AIDS. 2020 Oct 1;34(12):1755-1756. doi: 10.1097/QAD.0000000000002648. AIDS. 2020. PMID: 32889850 Free PMC article. No abstract available.

9

Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options.

Bajema KL, Nance RM, Delaney JAC, Eaton E, Davy-Mendez T, Karris MY, Moore RD, Eron JJ, Rodriguez B, Mayer KH, Geng E, Garris C, Saag MS, Crane HM, Kitahata MM; Centers for AIDS Research Clinical Network of Integrated Systems (CNICS). Bajema KL, et al. Among authors: saag ms. AIDS. 2020 Nov 15;34(14):2051-2059. doi: 10.1097/QAD.0000000000002679. AIDS. 2020. PMID: 33055569 Free PMC article.

10

Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?

McNeil CJ, Lee JS, Cole SR, Patel SA, Martin J, Mathews WC, Moore RD, Mayer KH, Eron JJ, Saag MS, Kitahata MM, Achenbach CJ; on behalf of the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS). McNeil CJ, et al. Among authors: saag ms. AIDS. 2022 Apr 1;36(5):657-664. doi: 10.1097/QAD.0000000000003151. AIDS. 2022. PMID: 34923519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters